Podcasts about frcpc

Please visit answersincme.com/AVD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, three experts in diabetes discuss approved and emerging once-weekly insulin analogs. Upon completion of this activity, participants should be better able to: Identify patients with T2D who may benefit from basal insulin therapy, including those suited for once-weekly formulations; Assess the clinical data of approved and emerging once-weekly basal insulin analogs; Evaluate opportunities and challenges associated with once-weekly basal insulin therapy.

Vijay Ramaswamy, MD, PhD, FRCPC / Sébastien Perreault, MD, FRCPC / Lucie Lafay-Cousin, MD - Spot, Act, and Treat: Canadian Consensus Updates on Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

Vijay Ramaswamy, MD, PhD, FRCPC / Sébastien Perreault, MD, FRCPC / Lucie Lafay-Cousin, MD - Spot, Act, and Treat: Canadian Consensus Updates on Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

Vijay Ramaswamy, MD, PhD, FRCPC / Sébastien Perreault, MD, FRCPC / Lucie Lafay-Cousin, MD - Spot, Act, and Treat: Canadian Consensus Updates on Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

Dr. Pouya Azar stops by the show to talk about his recent article Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative. He discusses the potential benefits of transitioning patients with opioid use disorder from traditional to extended-release or long-acting buprenorphine within 7 days or 24 hours, respectively, of treatment, as well as challenges and future questions that arose from his narrative review. Pouya Azar, MD, FRCPC, DABAM, is a clinician-scientist in addiction psychiatry and pain medicine based in Vancouver, British Columbia, Canada. He serves as co-medical manager of the Complex Pain and Addiction Service (CPAS) at Vancouver Coastal Health, a consult service providing management of pain, mental health disorders, and substance use disorders across Vancouver General Hospital, the University of British Columbia (UBC) Hospital, and GF Strong Rehabilitation Centre. He is also an assistant professor (tenure-track) in the UBC Department of Psychiatry, research scientist co-lead of the Substance Use Disorder Clinical Research Unit at the BC Centre for Excellence in HIV/AIDS, and a physician at the Vancouver General Hospital Transitional Pain Clinic. Dr. Azar's clinical and translational research focuses on developing novel opioid agonist treatment initiation and withdrawal management protocols, medical devices, digital health apps, and prevention programs to improve patient outcomes. - Article Link: Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative

Join us on September 17, 2025 at noon as we launch our sixth season of McGill Cares, a webcast series designed to support informal caregivers. During candid 30-minute interviews with leading experts, Claire Webster, Founder of the McGill Dementia Education Program, explores topics related to caring for a loved one who is living with dementia McGill Cares: Caring for someone with dementia: What you need to know about hallucinations, delusions and paranoia Simon Ducharme, MD, FRCPC, is a neuropsychiatrist and a clinician-scientist at the Douglas Mental Health University Institute and The Neuro (Montreal Neurological Institute-Hospital). He specializes in frontotemporal dementia and the interface between psychiatric disorders and dementia. Dr. Ducharme will shed light on how dementia can lead to delusions, hallucinations and paranoia. He will explain why these symptoms develop and how they impact both the person living with dementia and their care partners. He will then share practical strategies to help families manage these often-distressing situations so that they are better prepared to respond effectively, and will provide guidance on when it may be necessary to seek medical attention.This free webcast will be available in both English and French. ____________________________ McGill Cares is supported by the Amelia Saputo Community Outreach for Dementia Care. This webcast series is an initiative of the McGill University Dementia Education Program, which is funded by private donations. To contribute or for more information about our program, please visit http://www.mcgill.ca/dementia.If you have any topics or questions that you would like us to address during our monthly webcasts, please email us at dementia@mcgill.ca.

Soyez des nôtres le 17 septembre 2025 à midi pour le lancement de la sixième saison de McGill à vos côtés, une série de webémissions qui a pour but de soutenir les proches aidants. Lors d'entretiens sans artifice de 30 minutes avec des experts de premier plan, Claire Webster, fondatrice du Programme de formation sur les troubles neurocognitifs de McGill, explore des sujets liés aux soins d'un proche atteint d'un trouble neurocognitif. McGill à vos côtés : Prendre soin d'une personne atteinte d'un trouble neurocognitif : ce qu'il faut savoir sur les hallucinations, les troubles délirants et la paranoïa Simon Ducharme, MD, FRCPC, est neuropsychiatre et clinicien chercheur à l'Institut universitaire en santé mentale Douglas et au Neuro (Institut-hôpital neurologique de Montréal). Il est spécialiste des dégénérescences frontotemporales et de l'interface entre les troubles psychiatriques et les troubles neurocognitifs. Le Dr Ducharme expliquera comment les troubles neurocognitifs peuvent entraîner des délires, des hallucinations et de la paranoïa. Il nous dira pourquoi ces symptômes apparaissent et comment ils affectent à la fois la personne atteinte d'un trouble neurocognitif et ses partenaires de soins. Il partagera ensuite des stratégies pour aider les familles à gérer ces situations souvent pénibles afin qu'elles soient mieux préparées à réagir efficacement. Enfin, il donnera des conseils sur les cas où il peut être nécessaire de consulter un médecin.Cette webémission gratuite sera disponible en français et en anglais. ____________________________ McGill à vos côtés est parrainé par le programme Engagement communautaire Amelia Saputo pour les soins de la démence. Cette série de webémissions est une initiative du Programme de formation sur les troubles neurocognitifs de l'Université McGill, qui est financé par des dons privés. Pour contribuer ou pour en savoir plus sur notre programme, rendez-vous au http://www.mcgill.ca/démence.S'il y a des questions ou des sujets que vous aimeriez que nous abordions lors de nos webémissions mensuelles, envoyez un courriel à dementia@mcgill.ca.

Natasha Leighl, MD, MMSc, FRCPC, FASCO - Targeting Improved Outcomes in ALK-Positive NSCLC: A Canadian Clinician's Guide to Optimizing Outcomes Across the Spectrum of Disease

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include:Management for suspected drug-resistant CMV infection Illustrative patient cases Gene mutations in CMV  Presenters:Atul Humar, MD, FRCPC, FASTProfessorDepartment of MedicineUniversity of TorontoEaton Family Chair in Transplant Infectious DiseasesAjmera Transplant CentreUniversity Health NetworkToronto, CanadaCamille Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious DiseasesInfectious Diseases DivisionMass General Brigham Endowed Cancer Chair IVMassachusetts General HospitalAssociate Professor, Harvard Medical SchoolBoston, MassachusettsLink to full program:https://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

This episode of the Global Hemophilia Report explores the long-overdue conversation about women with hemophilia. Experts discuss the challenges women face in getting diagnosed, the persistent gaps in clinical research and care, and the impact of outdated language and systemic bias. The panel highlights the need for better data, more inclusive clinical trials, and a shift in medical culture to ensure women with hemophilia are recognized and prioritized.    Guests: Michelle Sholzberg MDCM, FRCPC, MSc. Dawn Rotellini Len Valentino, MD Robert Sidonio, Jr., MD   Senior Advisor: Donna DiMichele, MD   Hosted by: Patrick James Lynch   Written by: Kay Vermeil   Featured Advertiser: Sanofi   Subscribe to the Global Hemophilia Report   Show Notes:   Presenting Sponsor: Presented by Sanofi Join Shellye as she shares her inspiring journey as a woman living with hemophilia. After years of unanswered questions, her diagnosis highlights the critical role of health literacy in bridging care gaps. Through advocacy, Shellye raises awareness and empowers underserved communities. Watch her story and see how health literacy can break barriers and transform lives. Click here to watch her story: Sanofi – See Hemophilia Through My Eyes: Women & Girls For too long, women and girls who bleed have been dismissed. Left out of the narrative. Ignored by the system. But not anymore. In our new film, “Dismissed,” meet Isabelle—a 15-year-old with hemophilia who's using her voice to uplift the unheard. Alongside her are four powerful stories of women challenging what's "normal" and demanding recognition, care, and justice. This is more than a film. It's a movement.

On this episode, Mary Caffrey, Executive Editor of AJMC and Evidence-Based Oncology (EBO), is joined by Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO Chief Medical Officer of the International Myeloma Foundation (IMF), was the primary interviewee and source for a recent EBO article. His insights in that piece highlight how the IMF's M-Power initiative builds trust and awareness through its 3-pillar approach: community engagement, primary care education, and improving care for patients. During the discussion, Mikael talks about how IMF's M-Power initiative is expanding with the organization's medical student scholars program, using patient narratives to encourage trial participation among Black patients, and navigating today's political climate around diversity, equity, and inclusion—all while pushing toward a future where lifesaving treatments and cures reach every patient who needs them. Stay tuned for this enlightening discussion on bridging the clinical trial gap.

Life Changes Show with Filippo Voltaggio and cohost Mark Laisure, with Executive Producer Dorothy Lee Donahue Compassion and Altruism for Better Health and Renewed Creativity - Ep851 Featuring Interview Guest, Radiologist, TEDx and Keynote Speaker, Certified Educator of Applied Compassion, and Founder of NexGenHealth Foundation, Dr. Mitchell Abrams, FRCPC; and Performance Guest, Winner of a Platinum Ticket on American Idol, Singer, Songwriter, Cam Amen, on The Life Changes Show, Episode 851 Interview Guest: DR. MITCHELL ABRAMS, FRCPC; and Performance Guest: CAM AMEN

Andrea Delrue, MD, FRCPC, MPLc - Advancing Diabetes Care: Integrating Newer Basal Insulin Formulations Into Clinical Practice

Andrea Delrue, MD, FRCPC, MPLc - Advancing Diabetes Care: Integrating Newer Basal Insulin Formulations Into Clinical Practice

Andrea Delrue, MD, FRCPC, MPLc - Advancing Diabetes Care: Integrating Newer Basal Insulin Formulations Into Clinical Practice

Today I host Dr. Mamta Gautam, MD, MBA, FRCPC, CPDC, CCPE, CPE. Mamta is an internationally renowned psychiatrist, consultant, certified coach, author and speaker. Focused on Physician Health and well-being since 1990, she is a trailblazer in this field and is known as the “The Doctor's Doctor”.  In the past 2 decades, she has expanded her work to include Leadership Development, to better address system-level factors that impact the wellbeing of healthcare workers.Discussion points:- Mamta's background & fascinating origin story (3:23)- how to pursue growth at work to create an enjoyable & sustainable career (6:45))- burnout - what are the key signs? (18:00)- preventative measures for burnout (21:33)- how relevant is financial literacy in combatting burnout? (27:22)- building resilience - the 5 C's (33:27)- where you can learn about Mamta's work (46:40)- closing thoughts (48:04)--------------------------------------------------------------------------------------------------------------This episode features Arya EHR - https://www.aryaehr.com/**I endorse only products/services I personally use or would use. Any income generated offsets the costs of running this podcastLinks:Mamta Gautam:X: https://twitter.com/PEAKMDLinkedIn: https://www.linkedin.com/in/mamta-gautam-peak-md-6a7a3422/Instagram: https://www.instagram.com/peak.md/Facebook: https://www.facebook.com/peakmd.ca/BlueSky: https://bsky.app/profile/peakmd.bsky.socialYatin Chadha:Email: beyondmdpodcast@gmail.com LinkedIn: Yatin Chadha

Join us on July 9th at noon for the next McGill Cares webcast to support informal caregivers. During candid, 30-minute interviews with leading experts, Claire Webster explores topics related to caring for a loved one with dementia.Aging gracefully: Understanding the science of the aging body and brainJosé A. Morais, MD, FRCPC, is Full Professor of Medicine at McGill University and Director of the Division of Geriatric Medicine, McGill University, as well as of the McGill University Health Centre (MUHC). Dr. Morais is Academic Lead of the Dementia Education Program within the McGill Faculty of Medicine and Health Sciences.Dr. Morais will answer questions about what it means to age from a scientific perspective, including all the systems in our body that can deteriorate over time and the lifestyle habits that help maintain health as we get older. This free webcast is available in English and French.______________________________________________McGill Cares is supported by the Amelia Saputo Community Outreach for Dementia Care.McGill Cares is an initiative of the McGill Dementia Education Program, which is funded by private donations. To contribute or for more information about our program, please visit http://www.mcgill.ca/dementia.  This page also contains a link to trusted resources specific to dementia.  If you have any topics or questions that you would like us to address during our weekly webcasts, please email us at dementia@mcgill.ca.

Soyez des nôtres le 9 juillet à midi pour la prochaine webémission de la série McGill à vos côtés.  Lors d'entretiens sans artifice de 30 minutes avec des experts de premier plan, Claire Webster, conseillère en soins de l'Alzheimer et fondatrice du programme de formation sur la démence de McGill, explorera des sujets liés aux soins d'un proche atteint de démence.Vieillir avec élégance : comprendre la science du vieillissement du corps et du cerveauJosé A. Morais, MD, FRCPC, est professeur titulaire de médecine à l'Université McGill ainsi que directeur de la Division de gériatrie de l'Université McGill et du Centre universitaire de santé McGill (CUSM). Le Dr José A. Morais est aussi responsable académique du Programme de formation sur les troubles neurocognitifs de la Faculté de médecine et des sciences de la santé de McGill.Le Dr Morais répondra à des questions sur le vieillissement du point de vue scientifique, en abordant tous les systèmes de notre corps qui peuvent se détériorer avec le temps et les habitudes de vie qui permettent de rester en bonne santé en vieillissant. Cette webémission est disponible en français et en anglais______________________________________ McGill à vos côtés est parrainé par le programme Engagement communautaire Amelia Saputo pour les soins de la démence. McGill à vos côtés est une initiative du programme de formation sur la démence de McGill, qui est financé par des dons privés. Pour contribuer ou pour en savoir plus sur notre programme, rendez-vous au www.mcgill.ca/demence. Cette page contient également un lien vers des ressources fiables spécifiques à la démence. Si vous souhaitez nous voir aborder des sujets et des questions spécifiques durant nos webémissions, écrivez-nous à dementia@mcgill.ca. 

Ashkan Shoamanesh, MD, FRCPC - Can We Find a New Way Forward in Secondary Stroke Prevention? Exploring the Rationale and Potential Roles for Factor XIa Inhibition

Natasha Leighl, MD, MMSc, FRCPC, FASCO - Raising the Bar With Immunotherapy in Early-Stage NSCLC: Insights to Inform Treatment Decisions

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/ZAF865. CME/MOC credit will be available until June 15, 2026.Mastering the Evidence and Establishing Best Practices for Making Well-Informed Precision Decisions in EGFR-Mutated NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/ZAF865. CME/MOC credit will be available until June 15, 2026.Mastering the Evidence and Establishing Best Practices for Making Well-Informed Precision Decisions in EGFR-Mutated NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Johnson & Johnson.Disclosure information is available at the beginning of the video presentation.

Alice YY Cheng, MD, FRCPC - Elevating Care for T2D: Translating the Latest Advances on Incretin-Based Therapies to Practice

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SUC865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until May 18, 2026.AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Guide Treatment Decisions in Primary Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

Krista Noonan, BSc, MD, FRCPC / Elizabeth R. Plimack, MD, MS, FASCO - Redefining the Standards of Care in RCC: Expert Insights to Translate Recent Advances to Clinical Practice

Comments or feedback? Send us a text! Dr. Chris Taplin,a psychiatrist and founder of Ottawa's TMS Life clinic, joins us for a deep dive into one of the most promising frontiers in psychiatric care: Transcranial Magnetic Stimulation, or TMS. As clinicians, many of us have encountered the heartbreak of treatment-resistant depression — watching clients struggle despite best-practice psychotherapy and pharmacology. TMS offers a non-invasive, evidence-based alternative that is reshaping how we approach these cases. In this conversation, we unpack the science, patient experience, clinical decision-making, and broader implications of this technology. Whether you're a skeptic, a curious clinician, or already working with neuromodulation, I think you'll find this a thoughtful, grounded look at where TMS fits in the future of mental health treatment.Topics We Cover:

Mike Sharma, MD, MSc, FRCPC - Can We Set a New Standard of Care for Secondary Stroke Prevention? Evaluating Current Gaps and Future Goals

Denise Black, MD, FRCSC / Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP - Navigating the Menopause Transition With Your Patients: Experts Answer Key Questions

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026.BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026.BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026.BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026.BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026.BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DWJ865. CME credit will be available until April 2, 2026.BTK Inhibition as an MS Treatment Strategy: Targeting Smoldering Neuroinflammation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Sanofi.Disclosure information is available at the beginning of the video presentation.

Join Executive Producer and Host Shravani Durbhakula, MD, MPH, MBA, and Co-Host Mustafa Broachwala, DO, for a pivotal episode of the Pain Matters Podcast where we address the recent BMJ publication, “Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomized trials,” and the associated guideline. Steven Cohen, MD, Feinberg School of Medicine Northwestern University, Lynn R. Kohan, MD, University of VA Medical School, Zachary McCormick, MD, University of Utah, Nathaniel M. Schuster, MD, University of California, San Diego, Daniel Larach, MD, MS, MA, Vanderbilt University, Hance Clarke, MD, FRCPC, PhD, University of Toronto and President of the Canadian Pain Society, Hemant Kalia, MD, MPH, FIPP, Invision Health, and present diverse perspectives on the publication's claims and the systematic review and meta-analysis methods behind it.In this episode, you'll learn:The podcast underlines the necessity for comprehensive, unbiased systematic reviews and meta-analyses to inform clinical guidelines effectively.Experts caution against the misinterpretation of studies and the potential consequences for policy and access to interventional pain procedures.Advocates call for unified efforts in the pain medicine community to pursue legislative and regulatory reforms that align with current evidence and patient needs.The conversation underscores the pivotal role of personalized patient care and clinically validated techniques in improving outcomes and preserving practice legitimacy.The podcast highlights the risk of reducing access to viable interventional pain treatments if skewed interpretations of data shape healthcare policies.Tune in to discover how these leading experts address the controversies, advocate for robust clinical evidence, and highlight the urgent need for unified advocacy in shaping practical, patient-centered guidelines.Be sure to subscribe so you don't miss our next episode.Reference:  Wang X, Martin G, Sadeghirad B, Chang Y, Florez I D, Couban R J et al. Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomised trials BMJ 2025; 388 :e079971 doi:10.1136/bmj-2024-079971

Join me for a fascinating conversation around an exciting breakthrough in dementia detection that's offering real hope for early intervention. Dr. Hans Frykman, Chief Scientific Officer at Neurocode Laboratories, is here to share groundbreaking insights into cutting-edge biomarkers that can identify pathology associated with Alzheimer's disease before symptoms even appear. What's even more fascinating is how these same tools are revealing neuroinflammation caused by infections, including COVID, Lyme disease, and mold exposure—issues that are incredibly relevant in functional medicine today. The assays Dr. Frykman and his team have developed, and continue to research, are transforming the way we think about diagnosing and addressing neurodegeneration. We're talking about a potential game-changer that allows us to intervene earlier, reverse damage, and ultimately improve the trajectory of these conditions. This is an extraordinary time in science and medicine, and the work we're discussing today is at the forefront of it all. Don't miss out on how this could reshape your practice. ~DrKF Check out the show notes at https://tinyurl.com/2t55s3y3 for the full list of links and resources. GUEST DETAILS Dr. Hans Frykman, MD PhD FRCPC hfrykman@neurocode.com Hans Frykman MD, Ph.D., FRCPC is the founder, CEO, and medical director of BC Neuroimmunology Lab located in the UBC hospital on the University of BC campus in Vancouver BC. He is the medical director for Lykke Lab a genetics laboratory also on the University of BC campus. Also, he is the CSO for Neurocode Lab Inc. in Bellingham WA, a high-complexity, specialty lab focused on neuroimmunology and biomarkers in neurodegeneration. Dr. Frykman has a clinical faculty position at the University of British Columbia, Faculty of Medicine, Division of Neurology. THANK YOU TO OUR SPONSORS DIAMOND DUTCH: https://dutchtest.com/for-providers Biotics Research: https://www.bioticsresearch.com/ GOLD TimeLine Nutrition: https://tinyurl.com/bdzx2xms Vibrant Wellness: https://www.vibrant-wellness.com/ EXCLUSIVE OFFERS FROM OUR SPONSORS OneSkin: Get 15% off OneSkin with the code DRKARA at oneskin.co/DRKARA Try Qualia NAD+ for up to 50% off! Visit http://qualialife.com/kara15 and use code KARA15 at checkout for an additional 15% off your entire purchase! Why MitoQ's mitochondria-targeting is a critical step for your healthspan and longevity strategy. https://tinyurl.com/2b5benmd Want more? CONNECT WITH DrKF Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. For major FDA decisions in the field of neurology, we release short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we cover the recent approval of Genentech's tenecteplase, marketed as TNKase, as a new treatment for adults with acute ischemic stroke (AIS). The thrombolytic medicine is an intravenous tissue plasminogen activator that is clot-dissolving, administered as a single 5-second intravenous bolus. Tenecteplase is only the second such approval for this indication, following the 2015 approval of alteplase (Activase; Genentech); however, tenecteplase is considered faster and more simply administered than alteplase. To better understand the implications of this approval, NeurologyLive sat down with stroke expert Bijoy Menon, MD, MSc, FRCPC, a professor of neurology at the University of Calgary. In the interview, Menon talked about the downstream impacts of having another approved therapy, how tenecteplase differs from other thrombolytic agents, and the efficacy and safety that supported its approval. Furthermore, he provided commentary on how the approval continues to chip away toward the idea of precision medicine and personalizing treatments for patients with AIS.  For more of NeurologyLive's coverage of sodium oxybate's (Lumryz) expanded indication, head here: FDA Approves Tenecteplase for Acute Ischemic Stroke Episode Breakdown: 1:40 – Immediate reaction and significance of tenecteplase approval 5:30 – Safety considerations and administration when prescribing tenecteplase 10:20 – Supportive efficacy and safety, phase 3 AcT trial, and other supplementary studies 14:50 – Advancing precision medicine, treatment personalization with new approval Thanks for listening to the NeurologyLive Mind Moments podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

In this episode Nicholas Chadi MD, MPH, FRCPC, FAAP, explains how pediatricians can help families avoid the misuse of prescription drugs. Hosts David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also talk to Michael Pitt, MD, FAAP, and Rheanne Maravelas, MD, about medical jargon and its effect on children's understanding. For resources go to aap.org/podcast.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).Disclosure information is available at the beginning of the video presentation.

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another episode of "Ditch the Labcoat," the podcast that brings a critical, science-based perspective to healthcare discussions. I'm your host, Dr. Mark Bonta, and today we dive deep into the intersection of nutrition and surgery. Joining us are Dr. Sagar Desai, an orthopedic surgeon, and Dr. Kyle Waldman, an anesthesiologist.We'll explore the influence of pharmaceutical companies in medicine, the importance of non-drug interventions, and how nutritional modifications can offer significant patient benefits. Our focus will be on immuno and pharmaco nutrition—innovative approaches combining amino acids, omega-3s, vitamins, and other nutrients to improve surgical outcomes and patient recovery.Sagar and Kyle will share their entrepreneurial journey with Proven Therapeutics, aiming to provide better perioperative care. We'll discuss the challenges of patient compliance, the evidence supporting these nutritional strategies, and the practicalities of implementing them in both academic and community settings.Plus, for a bit of levity, we'll be addressing some of the common stereotypes in the medical profession and the humorous side of our intense, life-saving work.So, grab your headphones and get ready to ditch the labcoat. Let's jump into a conversation that blends serious science with a touch of humor, all in the pursuit of better healthcare.06:21 - Unexpectedly switched career focus from orthopedics to internal medicine.09:32 - Steroids and diet significantly impact bowel surgery recovery.10:39 - Oral immunonutrition reduces the risk of anastomotic leaks.16:33 - Nutritional changes can outperform medications after heart attacks.17:26 - Nutrition data from general surgery applies to orthopedics as well.22:44 - Challenges and strategies for managing surgical anesthesia effectively.23:53 - Perioperative immunonutrition addresses the surgical stress response.28:12 - Evidence-based nutritional products are underutilized despite proven benefits.32:08 - Healthcare workers are genuinely dedicated to helping patients.37:18 - Thorough research ensures positive feedback on nutritional products.43:52 - Low financial risk, careful work, and significant patient benefits.45:29 - Enjoyable interviews with intellectual, humorous, and influential guests.47:28 - Evidence-based treatments are often overlooked in medical prescriptions.

Is the medical publishing industry a scam?  As the open access model has grown, pay-to-publish has helped large publishers maintain profit margins similar to that of large tech companies.  The problem?  They do so by exploiting the blood, sweat, and tears of academics and the institutions that support them.   Join Dr. Patrick Georgoff (@georgoff, Duke Surgery), Dr. Ayman Ali (BTK education fellow, Duke Surgery), and special guest Dr. Allan Detsky for an engaging discussion.  Paper discussed: The Changing Medical Publishing Industry: Economics, Expansion, and Equity (https://link.springer.com/article/10.1007/s11606-023-08307-z) DR. ALLAN S. DETSKY, MD, PhD, FRCPC, CM is Professor, Institute of Health Policy, Management and Evaluation, and Department of Medicine at the University of Toronto; former Physician-in-Chief, Mount Sinai Hospital(1997-2009); and former Head of the Division of General Internal Medicine at The Toronto Hospital and University of Toronto (1987-1997). Dr. Detsky received his B.S. from Massachusetts Institute of Technology, his M.D. from Harvard Medical School, and his Ph.D. (in Economics) from Massachusetts Institute of Technology in 1978.  He has served on the editorial board of the New England Journal of Medicine, and as a member of the Drug Quality and Therapeutics Committee for the Province of Ontario where he spearheaded the effort to formally include cost-effectiveness considerations into the Canadian drug reimbursement process. Dr. Detsky has received 2 Tony nominations as a producer (Jesus Christ Superstar 2012, Come From Away 2017 and an Olivier Award for Best Musical in 2018. In June 2018, he was appointed by the Governor General to the Order of Canada. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen